Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page
- Check6 days agoChange DetectedThe screenshots show only visual/layout adjustments and an updated timestamp; no substantive changes to the study details.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2. There are no evident changes to the core study details or content.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. No other content on the page appears to have changed.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary toggle and updated QC metadata to show 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with 'Revision: v3.4.0'; the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This is an administrative update with no changes to study details or how users interact with the page.SummaryDifference0.1%

- Check49 days agoChange DetectedNo significant changes to the study content or locations; only minor UI elements appeared (cookie banner). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.